tetradecanoylphorbol acetate and Dermatitis Medicamentosa

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Disease Models, Animal; Drug Eruptions; Flavones; Gene Expression Regulation; I-kappa B Proteins; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; RAW 264.7 Cells; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate

Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Carcinogens; Cyclooxygenase 2; Drug Eruptions; Female; Gene Expression Regulation; Humans; Keratinocytes; Mice, Inbred ICR; Ornithine Decarboxylase; Skin Neoplasms; Stilbenes; Tetradecanoylphorbol Acetate

Topics: Acute Disease; Animals; Antigens, Differentiation, B-Lymphocyte; Carcinogens; Cell Line; Chronic Disease; Disease Models, Animal; Drug Eruptions; Epidermis; Histocompatibility Antigens Class II; Humans; Inflammation; Interferon-gamma; Intramolecular Oxidoreductases; Keratinocytes; Macrophage Migration-Inhibitory Factors; Mice; Natural Killer T-Cells; Neovascularization, Pathologic; Receptors, Interleukin-8B; Tetradecanoylphorbol Acetate

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Drug Eruptions; Enzyme Activation; Female; Hair Follicle; HeLa Cells; Humans; Keratinocytes; Ligands; Male; Mice; Neutrophils; Protein Kinase C-alpha; Receptors, Interleukin-8B; Skin Neoplasms; Tetradecanoylphorbol Acetate

Topics: Administration, Topical; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Diterpenes; Drug Eruptions; Enzyme Activation; Humans; Keratinocytes; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Protein Binding; Protein Kinase C; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Croton Oil; Dinitrofluorobenzene; Diterpenes; Drug Eruptions; Hyperplasia; Indicators and Reagents; Interleukin-17; Interleukin-23; Lactones; Male; MAP Kinase Kinase Kinase 1; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Ornithine Decarboxylase; Peroxidase; Protein Kinase Inhibitors; Psoriasis; Skin; T-Lymphocytes; Tetradecanoylphorbol Acetate

Topics: Acetates; Animals; Cyclooxygenase 2; Cytokines; Drug Eruptions; Epidermis; Female; Hyperplasia; Mice; Mice, Inbred SENCAR; NF-kappa B; Proto-Oncogene Proteins c-jun; Receptors, Glucocorticoid; RNA, Messenger; Skin; Tetradecanoylphorbol Acetate; Transcriptional Activation; Tyramine

Topics: Acute Disease; Administration, Cutaneous; Animals; Dermatologic Agents; Dimethyl Sulfoxide; Drug Eruptions; Edema; Erythema; Irritants; Male; Mice; Neutrophil Infiltration; Tetradecanoylphorbol Acetate; Urocanic Acid

Topics: Acute Disease; Animals; B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Chemokines, CXC; Chemotaxis, Leukocyte; Culture Media, Conditioned; CX3C Chemokine Receptor 1; Drug Eruptions; Exanthema; Humans; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-4; Ionomycin; Membrane Proteins; Mice; Neutrophils; Receptors, Chemokine; Receptors, CXCR; Receptors, CXCR4; Receptors, G-Protein-Coupled; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Skin; Skin Diseases, Vesiculobullous; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate; Transfection; Tumor Necrosis Factor-alpha

Topics: Administration, Rectal; Animals; Anti-Allergic Agents; Calcimycin; Calcium; Cell Line; Dinitrophenols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Eruptions; Drug Hypersensitivity; Drugs, Chinese Herbal; Histamine Release; Humans; I-kappa B Proteins; Injections, Intraperitoneal; Interleukin-6; Lycopus; Male; Mast Cells; Mice; Mice, Inbred ICR; NF-kappa B; NF-KappaB Inhibitor alpha; p-Methoxy-N-methylphenethylamine; p38 Mitogen-Activated Protein Kinases; Phytotherapy; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Carcinogens; Cell Growth Processes; Cell Transformation, Neoplastic; Cyclic AMP; Dinoprostone; Drug Eruptions; Female; Hyperplasia; Keratinocytes; Mice; Mice, Knockout; Neovascularization, Pathologic; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Drug Eruptions; Flavonoids; Gene Expression Regulation; Interleukin-1; Male; Mice; Mice, Inbred ICR; Plant Extracts; Prednisolone; RNA, Messenger; Tetradecanoylphorbol Acetate

Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Benzopyrans; Disease Models, Animal; Drug Eruptions; Drug Evaluation, Preclinical; Ear, External; Edema; Female; Gels; Guinea Pigs; Humans; Male; Mice; Peroxidase; Psoriasis; Receptors, Leukotriene B4; Tetradecanoylphorbol Acetate

Topics: Animals; Biomarkers; Carcinogens; Drug Eruptions; Female; Mice; Neutrophils; Peroxidase; Skin; Tetradecanoylphorbol Acetate

Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrophy; Cyclooxygenase Inhibitors; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Female; Hydrocortisone; Hydroxamic Acids; Lipoxygenase Inhibitors; Mice; Rats; Rats, Sprague-Dawley; Skin; Tetradecanoylphorbol Acetate

Topics: Administration, Cutaneous; Animals; Atrophy; Croton Oil; Drug Eruptions; Ear, External; Edema; Female; Fibronectins; Glucocorticoids; Glycosaminoglycans; Inflammation; Mice; Mice, Hairless; Skin; Tetradecanoylphorbol Acetate; Tretinoin

Topics: Animals; Antibodies, Monoclonal; CD18 Antigens; Chemotaxis, Leukocyte; Drug Eruptions; Eosinophilia; Eosinophils; Guinea Pigs; Integrin alpha4beta1; Integrins; Polysaccharides; Receptors, Lymphocyte Homing; Selectins; Skin; Tetradecanoylphorbol Acetate

Topics: Acetylglucosaminidase; Administration, Topical; Animals; Arachidonic Acid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Eruptions; Eicosanoids; Isoenzymes; Male; Mice; Mice, Inbred Strains; Peroxidase; Prostaglandin-Endoperoxide Synthases; Tetradecanoylphorbol Acetate

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antioxidants; Carcinogens; Cell Line; Citrus; Cyclooxygenase 2; Dinoprostone; Drug Eruptions; Female; Flavones; Flavonoids; HL-60 Cells; Humans; Interferon-gamma; Isoenzymes; Lipopolysaccharides; Macrophage Activation; Macrophages; Membrane Proteins; Mice; Mice, Inbred ICR; Nitric Oxide; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Skin; Skin Neoplasms; Superoxides; Tetradecanoylphorbol Acetate

Topics: Adjuvants, Immunologic; Administration, Topical; Animals; Clofibrate; Dermatitis, Allergic Contact; Drug Eruptions; Female; Interleukin-1; Irritants; Linoleic Acid; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Oxazolone; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Necrosis Factor-alpha

Topics: Animals; Anti-Inflammatory Agents; Antigens, Differentiation; Antineoplastic Agents, Hormonal; Calcium; Calcium-Binding Proteins; Calgranulin A; Calgranulin B; Carcinogens; Carcinoma, Squamous Cell; Dexamethasone; Disease Progression; Drug Eruptions; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, fos; Keratinocytes; Leukocytes; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Papilloma; Protein Kinase C; Proto-Oncogene Proteins c-fos; S100 Proteins; Skin Neoplasms; Specific Pathogen-Free Organisms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1